Ketki Vispute

Associate Director, Manufacturing • Autolus Therapeutics

Ketki has 10+ years of experience in the development and manufacturing of CAR-T cells for haematological malignancies. Ketki’s team was the first in Europe to launch the first-ever CAR-T cell clinical trial starting from designing the CAR construct to pre-clinical development followed by scale-up of the process and manufacturing for the clinic. Ketki has delivered 4 phase 1/2 clinical trials in CAR-T therapy and is now working towards commercialising CAR-T manufacturing in the UK. 

Also speaking

Frank Luppino

President & Chief Executive Officer • Remedium Bio

Beth Gardner

Senior Director, Patient Supply • Beam Therapeutics

Stuart Curbishley

Chief Manufacturing & Development Officer • adthera bio

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.